Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SHB001 (topical azithromycin) for Lyme disease prevention
NCT01243008Phase 2Completed
- Sponsor
- University of Zurich
- Start
- Apr 2010
- Primary completion
- Nov 2010
- Countries
- 1
01
Overview
Phase 2, randomised, single-blind trial of azithromycin in Lyme disease, sponsored by University of Zurich. Primary endpoint: Local safety at 7 days. Started Apr 2010; status: completed.
02
Drugs
azithromycin
03
Conditions
Lyme disease
Beyond the preview
Go deeper on NCT01243008.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01243008.